In vitro culture of day-1 5.5 murine fetal liver (FL) cells in the presence of recombinant interleukin-2 (IL-2) results in the expansion of FcyRII/III+CD3-Ti-NK1.1 + cells displaying both natural killer (NK) and antibody-dependent cell cytotoxicity (ADCC) cytolytic activities. These FL-derived NK cells express FcyRlll (CD16) in association with an FctRlr homodimer on their surface. In contrast, in vitro expansion of FL cells in the absence of IL-2 generates noncytotoxic cells belonging to the myelomonocytic lineage (Mac1 'Grl +NK1.1-). Hence, IL-2 appears to be critical for the proliferation and differentiation of NK cells from FL progenitors. Experiments in which FL cells were fractionated by density gradient centrifugation before in vitro expansion showed that NK progenitors are contained within ATURAL KILLER (NK) cells are large granular lym-N phocytes (LGL) displaying non-major histocompatibility complex (MHC) restricted cytolytic activity against conventional targets.'-3 NK cells lack a T-cell receptor (CD3-Ti) complex, but express characteristic surface markers, including the low-affinity receptor for the Fc fragment of IgG (FcyRIII and CD 16) and NKl. 1 in the appropriate mouse strains.'6 In addition, NK cells share certain cell surface molecules (ie, CD2 and Thyl) in common with mature T lymphocytes.'" Although NK cells are known to originate from bone marrow precursors in the adult,' the developmental origin of NK cells during fetal life and their relationship to the T-cell lineage are still unknown. It has alternatively been proposed that NK cells are closely linked in their lineage to that of immature T lymphocyte^^^^ or that of myelomonocytic cells,'" or that NK cells constitute a separate lineage distinct from T or B Recently, we identified a novel thymocyte subpopulation during early murine fetal development (day 15.5 of gestation) lacking mature T-cell markers (ie, CD4, CD8, and CD3-Ti) but expressing FcyRIIIIII receptor^.'^ These cells were capable of differentiating in vivo after intrathymic transfer into a congenic host animal into CD4+CD8+CD3-Ti"" FcyRII/III-cells and subsequently into CD4+CD8-, CD3-Tihiph FcyRII/III-or CD4-CD8+CD3-Tihi@' FcyRIII 111-single-positive (SP) mature T cells. In contrast, expansion of these early thymocytes in vitro in the presence of human recombinant interleukin-2 (rIL-2) was shown to prevent their differentiation along the T-cell pathway, to maintain their NK-like phenotype, and to induce them to develop a strong cytotoxic activity against the NK target YAC-1 . I 3 These experiments established that a population of early fetal thymocytes expressing FcyRIIIIII receptors contains both T-cell and NK progenitors.
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In view of these observations, we have now analyzed day-15.5 fetal liver (FL) cells for their NK and T-cell progenitor activity in the present study. Herein, we show that in vitro culture of FL cells in the presence of rIL-2 generates FcyRII/III+ NKl. I + cells displaying NK and antibody-dependent cell cytotoxicity (ADCC) effector functions. In contrast, after direct intrathymic injection into a recipient a cell population with a density of 1.04 < d < 1.08 g/mL. Cells with d > 1.08 g/mL (representing 240% of FL cells) have no such NK progenitor activity. In addition, after intrathymic injection into Ly5 congenic host animals, day-15.5 CD4-CD8-FL cells mature into CD4+CD8+ thymocytes within 12 days. Interestingly, this T-cell progenitor activity is restricted to subpopulations of FL cells that also contain NK progenitors, but is absent in high-density (d > animal, CD4-CD8-FL cells differentiate into CD4+CD8+ thymocytes. Thus, the behavior of FL progenitors is similar to that of fetal thymocyte progenitor^.'^ In addition, both NK and T-cell progenitor activities are restricted to cells whose density is between 1.04 and 1.08 g/mL. Our data also show that at least a fraction of NK (and T-lymphocyte) progenitors expresses Fc receptors for IgG within FL.
MATERIALS AND METHODS

Monoclonal antibodies (MoAbs). indirect immunofluorescence assays, and cell sorting analysis.
First-step antibodies used in the present study are 2.462 (anti-FcyRIIIIII), PKl36 (anti-NK1. I), J1 Id (anti-heat stable antigen [HSA]), 7D4 (anti-IL-2 receptor, p55), RM2-1 (anti-CD2), 145-2C11 (anti-CD3c), Y 13-238 (antip2 1 Ras), GK1.5 (anti-CD4), 53-6.7 (anti-CD8), H57-597 (antiTia-P), 3A 10 (anti-Tiy/G), 104-2-1 (anti-Ly5. l), B220 (anti-B lymphocytes), Mac 1 (antimacrophages), and Gr 1 (antigranulocytes)." Second reagents used are goat antirat fluorescein isothiocyanate (FITC; Tago, Burlingame, CA), goat antimouse FITC (Whittaker Bioproducts, Walkersville, MD), or goat antihamster FITC (Caltag, San Francisco, CA). Immunofluorescence staining was performed by incubating 3 X lo5 cells with a first-step antibody (culture supernatant 1:2 or purified MoAb, 5 pg/mL final concentration) for 30 minutes on ice, and subsequently with the appropriate second-step reagent for an additional 30 minutes. Cells were then washed twice using RPMI 1640 plus 2% fetal calf serum (FCS) and 5,000 cells were analyzed on a fluorescence-activated cell sorter (FACScan; Becton Dickinson, Rutherford, NJ). For cell sorting of FcyRII/III+ cells, 5 X IO7 FL cells were incubated on ice for 30 minutes with IO pg/mL of 2.462 MoAb directly conjugated to HTC. Cells were washed twice and 2.4G2' cells were sorted using an EPICS 750 series cell sorter (Hialeah, FL). Sorted populations were reanalyzed before in vitro expansion and were routinely found to be 285% pure.
Animals and intrathymic injections. C57B1/6 (Ly5.1) mice were obtained from Jackson Laboratories (Bar Harbor, ME) and breeding stocks of the congenic strain B6Ly5.2 were kindly provided by Dr Clarence Reeder (National Cancer Institute, Frederick, MD). Fetuses were obtained from timed pregnant mice (with the day of the vaginal plug counted as day I of pregnancy). FL cells obtained from several fetuses were pooled and filtered through a nylon mesh (Spectrum, Houston, TX) before use. For intrathymic injections, 4-to 6-week-old recipient mice (B6 Ly5.2) were irradiated (600 rad) using a 60Co y irradiation source (Atomic Energy of Canada LTD, Ottawa, Ontario, Canada). Intrathymic injections were performed as described el~ewhere.'~~" Briefly, mice were anesthetized with Avertin (2.5% solution, 10 pL/g body weight) and injected intrathymically using a 1 mL syringe (Becton Dickinson) placed on a Tridak Stepper (Tridak, Brookfield, CT). Cells ( 1 to 1.2 X IO5) were injected, in a volume of 20 pL per lobe, by positioning the needle from craniolateral to caudomedial and injecting through the thorax wall above the clavicle. FL cells ( IO5 per well) were expanded in 96-well round-bottom plates (Nunc, Bedford Park, IL) over a feeder layer composed of irradiated (6,000 rad) syngeneic splenocytes (50,000 cells/well) plus A20 cells (murine B-lymphoma cells, 20,000 cells/well). Cells were grown in RPMI 1640 plus 10% FCS, 1 mmol/L sodium pyruvate, 2 mmol/L L-glutamine, and antibiotics in the presence of exogenous recombinant human IL-2 (1 50 U/mL; Biogen, Cambridge, MA). Fresh IL-2 containing medium was added every 3 to 4 days. After approximately 2 weeks in culture, cells were harvested and characterized. For limiting dilution assays, various cell concentrations (ranging from 6.25 X IO3 to 5 X IO5 cells/well) were seeded as above using 24 wells/cell concentration. After 2 weeks in culture, 5,000 radiolabeled YAC-I target cells were added to each well to determine the cytolytic activity. The mean plus 3 standard deviation ofcpm corresponding to 51Cr released by control cultures containing only feeder cells was used to determine the threshold for defining a culture positive for NK lytic activity.16 The percentage of negative wells derived from 24-well cultures was determined for each cell concentration tested. Frequency of NK progenitors was calculated using a minimum xz estimation, as described elsewhere.I6 According to Taswell,17 an estimation was accepted when the probability value was P < .05.
Cytotoxicity assays. Cytotoxicity assays were performed in 96-well V-bottom plates (ICN-Flow Labs, Horsham, PA). A total of IO6 target cells were labeled for 1 hour at 37°C using 100 pCi 5LCr (NEN, Boston, MA) and washed twice; 5,000 target cells/well were incubated with various concentrations of effector cells for 4 hours at 37°C. Percent specific lysis was calculated from a triplicate determination (with SD 5 5%). Targets used in the present study are YAC-I (a conventional murine NK target) and EL-4 (murine thymoma Percoll gradients. FL cells were layered over a discontinuous density gradient of Percoll (Pharmacia, Uppsala, Sweden) prepared following the manufacturer's recommendations. Briefly, a stock suspension of density (d) = 1.13 g/mL (9 V Percoll/l V NaCl 1.5 mol/L) was prepared. Unless otherwise specified, 6 dilutions of this stock Percoll suspension were made either in RPMI 1640 or in PBS to visualize each layer. Two milliliters of each dilution was layered in a 15-mL conical tube. Percoll concentrations (vol/vol) and corresponding densities (in grams per milliliter) are 30% (1.04), 50% (1.06), 65% (1.08), 74% (1.09), 82% ( I . IO), and 100% ( I . 13). Routinely, 6 to 8 such gradients were prepared in parallel, and 2 X IO7 FL in 0.5 mL of RPMI 1640 were layered on top ofeach individual gradient. Tubes were spun at 550gfor 20 minutes at room temperature. Fractions numbered 1 (low density) to 5 (high density) from top to bottom of the gradient were collected from each tube and pooled. Cells were then washed twice using RPMI 1640 plus 2% FCS before in vitro expansion or intrathymic injection. PCR experiments were conducted as described e1~ewhere.l~ Briefly, total RNA was extracted from 5 X IO6 cells using the vanadyl ribonucleoside complex method. Cells used for RNA extraction include ex vivo day-15.5 FL cells, cultured NK cells derived from FL, and 2 fetal-thymus cell lines derived from fetal thymocytes after transformation with the retroviral construct J2,'* 34.14 derived from day 14 and C3H-B3 derived from day 17 of gestation (both kind gifts of Dr A. Kruisbeek, Netherlands Cancer Center). One microgram of RNA was used to synthesize single-strand cDNAs with an oligo-dT synthetic primer and 200 U of Moloney murine leukemia virus reverse transcriptase (BRL). With this material as a template, 35 cycles of amplification were performed using a Gene Amp kit (Perkin ElmerCetus, Nonvalk, CT) under the following conditions, 94°C for 1 minute, 60°C for 1 minute, and 72°C for 0.5 minute. Amplimers used were bp 471 through 490 (FcyRIII cDNA, sense amplimer common to all 3 Fc-receptor isoforms); bp 789 through 81 1 (FcyRIII cDNA, antisense amplimer generating an FcyRIII specific 265-hp fragment); and bp 1214 through 1233 (FcyRIIbI cDNA, antisense amplimer generating a 48 I-bp fragment specific for FcyRIIbl and a 345-bp fragment specific for FcyRIlb2) (all hp numbers correspond to Ravetch et aii9). PCR products were separated on a 1.5% agarose gel, denatured in 0.25 mol/L HCI, transferred onto blotting membrane (BioRad, Richmond, CA) in 0.4 mol/L NaOH, and probed with a '*P-labeled internal oligonucleotide specific for the three Fc-receptor isoforms (bp 922 through 941 in the FcyRIIl cDNA).
Immunoprecipitations and Western blot analysis. Cells (2 X IO7) were surface-labeled with 1 mCi of "'I (Amersham, South Clearbrook, IL) by the lactoperoxidase method. Cells were lysed in RIPA buffer (1% Triton X-100, 150 mmol/L NaCl, 10 mmol/L NaH,PO,, 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L NaF, 1 mmol/L phenylmethylsulfonyl fluoride, 10 mmol/L iodoacetamide plus protease inhibitors). Lysates were precleared using CNBr-activated Sepharose beads coupled with an irrelevant (GK1.5) antibody and incubated overnight at 4°C with Sepharose beads coupled with purified 2.4G2 antibody (2 mg/mL beadsuspension). Immunoprecipitates were washed four times with RIPA buffer and resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). For immunoblotting experiments, 3 X IO' cells were lysed in a 1% digitonin lysis buffer and
Polymerase chain reaction (PCR)
For personal use only. on October 25, 2017. by guest www.bloodjournal.org From immunoprecipitations were conducted as above. Samples were subjected to two-dimensional nonreducing/reducing SDS-PAGE, and proteins were transferred to nitrocellulose membranes (Schleicher and Schuell, Keene, NH). Blots were subsequently probed with rabbit heteroantisera directed against either CD3{ and CD3q (antiserum 387)20 or FccRIy (antiserum 7666, a kind gift from Drs J.P. Kinet and M.H. Jouvin, National Institutes of Health, Rockville, MD). Immunoreactive proteins were visualized by the enhanced chemoluminescence method (ECL; Amersham) according to manufacturer's recommendations.
RESULTS
In vitro expansion of NK cells ,from murine FL. As shown in Table 1 , the vast majority of ex vivo FL cells obtained from day 15.5 C57B1/6 fetuses lack surface expression of markers associated with either T-(CD3, CD4, CD8, Thyl, CD2, Tia/P or Tiy/G) or B-(B220) lineage cells, macrophages (Macl), granulocytes (Grl), or NK cells (NKl.1). In contrast, virtually all ex vivo FL cells express the HSA antigen ( Table I ) as well as VLA-4 and Pgpl (not shown). Interestingly, a subpopulation of FL cells representing 5% to 15% ofthe cells was reactive with the antibody 2.462, which recognizes FcyRIIIIII receptors." In a first series of experiments, we attempted to specifically expand NK cells from this heterogeneous population using a culture system that proved successful in growing NK cells from fetal thymus.I3 For this purpose, cells were grown over a feeder layer of irradiated syngeneic splenocytes plus A20 murine B cells and exogenous rIL-2 was added to the culture medium every 3 to 4 days. Under these conditions, we observed within 2 weeks the proliferation of a population of FcyRIII III+NKl. 1 +Mac 1 -Gr 1 -cells (Fig 1 A) . In contrast to ex vivo day-1 5.5 FL cells, cultivated FL cells were found to express substantially lower levels of HSA, and a large fraction of these cells (30% to 100%) expressed a relatively high density of Thy1 (Fig 1A and Table 1 ). Cells with a similar phenotype were also expanded from FL. obtained from BIO.BR mice as opposed to C57B1/6. These cells were also expanded from FL as early as day 12 of gestation ( Table I) .
When tested for their cytolytic activity against the NK target YAC-I, cultured but not ex vivo FL cells displayed a strong NK activity (Fig IB, left panel) . Cultured FL cells were also tested for their capacity to mediate ADCC. To this end, NK-resistant EL-4 target cells were derivatized with 2, 4, 6 TNP to form EL-4 (TNP) and preincubated with a murine anti-TNP MoAb. These cells were subsequently analyzed for their susceptibility toward lysis by FL cells. As shown in Fig 1B (right panel) , these target cells were efficiently lysed by cultured FL cells (with 30% specific lysis at a 10: 1 E/T ratio), whereas no significant cytotoxicity (ie, 110%) was detected in the absence of the antihapten artibody (data not shown) or when control cells lacking the hapten were used as a target. Importantly, the ADCC activity mediated by cultured FL cells was totally inhibited by addition of the 2.462 antibody, indicating participation of an Fc receptor in the cytotoxic response. In addition, to evaluate the role of IL-2 in inducing the proliferation and/or differentiation of NK-FL progenitors, cultures were set in parallel using a feeder layer, as above, but omitting exogenous IL-2. Under these conditions, we consistently observed the proliferation of a population of FcyRII/III+ MacI+Grl+ cells. However, these cells did not express NK1.1, nor did they kill YAC-1 targets ( Table I ), indicating that they belong to the myelomonocytic lineage. That these cells react with 2.462, however, is not surprising given that this MoAb identifies several types of Fc receptors. Altogether, our results establish a critical role for IL-2 in inducing the in vitro differentiation of NK progenitors from FL into mature (functional) NK cells.
Characterization of Fc receptors-for IgG on NK cells de-
rivedfiom day-15.5 FL. The MoAb 2.4G2 recognizes several types of Fc receptors for IgG in addition to FcyRIII (CD16), including FcyRIIb 1, present on B lymphocytes, and FcyRIIb2, expressed on macrophage^.'^.^^ To determine which receptor isoforms are expressed within FL, we designed PCR experiments to specifically amplify the cDNAs corresponding to these receptors from cultured NK cells (FL.35) obtained from day-15.5 ex vivo FL cells as above. Such analysis showed that cells from the 34.14 cell line (day-14 fetal thymocytes) and FL35 cells express CD16 (FcyRIII) (Fig 2A, upper panel, 265-bp fragment) . In addi- The NK activity was assayed against YAC-1 as is Fig 1B; -, <5%, and +, >50%, respectively, of specific lysis at an E/T ratio of 1O:l.
harvested and analyzed for their surface phenotype and NK cytotoxic activity.
For tion, a cDNA corresponding to FcyRIIb2 but not to FcyRIIbl could be amplified from FL35 cells. Note that the day-17 fetal thymocyte cell line C3H-B3, used as a control, expresses predominantly the FcyRIIb 1 mRNA. Although not shown, cDNAs corresponding to FcyRIII and FcyRIIb2 could be amplified from FL day-15.5 ex vivo cells. None of these PCR products was detected when the template was omitted (Fig 2A, control lanes) .
To verify the reactivity of the MoAb 2.462 with surface CDl6 in FL-derived NK cells, 2.462 immunoprecipitates were obtained from Triton X-100 lysates of cultured FL cells (FL59) radiolabeled with ' "I and then analyzed by SDS-PAGE. Such experiments showed that 2.462 specifically identifies a 50-to 60-Kd protein, which is consistent with the expected apparent molecular weight of CD16 ( Fig  2B, left panel) .21 Next, we analyzed whether this molecule was associated with FctRIy or related molecules (CD3Tand CD37) on FL-derived NK cells. For these experiments, MA76 cells (a murine T-T hybridoma lacking CD3l and CD37 mRNA in which surface expression of the T-cell receptor [TCR] has been restored by transfection of a CD37 cDNA) were used as a positive control. Cells were lysed in 1% digitonin to preserve receptor subunit interactions. Immunoprecipitates with 2.462 or the anti-CD3t-specific MoAb 2C11 were obtained from FL59 or MA76 cells, respectively, and analyzed by two-dimensional nonreducingl reducing SDS-PAGE. Subsequently, proteins were blotted onto nitrocellulose membranes and blots were probed using rabbit heteroantisera specific for either CD3c and CD37 or FctRIy as probes. As shown in Fig 2B ( (FL59) were iodinated by the lactoperoxidase method, and lysates were immunoprecipitated using either a control anti-CD4-antibody (GK1.5) or 2.4G2 coupled to Sepharose beads. Immunoprecipitates were analyzed on a 10% SDSpolyacrylamide gel under nonreduced conditions. In the right panel, 2.462 or 2 C l l immunoprecipitates were obtained from digitonin lysates of FL59 or MA76 (a murine T-T hybridoma expressing CD37 but not CD3t or F c A y as part of its TCR complex), respectively. Samples were resolved by 12% two-dimensional nonreducing/ reducing SDS-PAGE and electrophoretically transferred to nitrocellulose. Western blots were probed with heteroantisera specific for both CD3< and CD37 (top panels, antibody 387) or specific for FctRly (bottom panels, antibodyr666). Autoradiograms were developed using the ECL method and exposed for 1 minute with the exception of the gel corresponding to FctRlr in 2.462 immunoprecipitates from FL59 cells, which was exposed for only two seconds. scored for their NK cytolytic activity, as described in the Materials and Methods, and the percentage of negative wells (ie, lacking any NK activity) derived from 24 well-cultures per group was plotted versus cell concentrations ( Fig  3B) . The frequency of NK progenitors was then calculated using a minimum x2 estimation.16 Results representative of 3 independent experiments show that fractions F1 and F2 contain virtually all the NK progenitor activity. The analysis of progenitor frequencies suggests an approximately twofold enrichment of NK progenitors in fractions F1 and F2 (containing 1 NK progenitor per 10,100 and 10,800 cells, respectively) when compared with unfractionated FL cells (1/19,500 cells). In contrast, no detectable NK progenitor activity (ie, <]/lo6 cells) was found in cells with a density greater than 1.08 g/mL (corresponding to F3, F4, and F5 and representing 41% of the total population in this experiment). In Fig 3C , the average cytolytic activity per well obtained from these individual fractions against YAC-1 is plotted. The results provide additional evidence for the enrichment of NK progenitor activity in fraction FI and F2. Specific killing is approximately 20% in the 50 X IO3 seeded cultures of unfractionated FL, whereas a similar level of killing is observed at a 25 X lo3 cell seeded culture for F1 or F2. In contrast, cells from F3, F4, and F5 do not significantly kill YAC-I target cells.
In a previous study, we have shown that both T-and NK-cell progenitors within the thymus express FcyRII/III receptors during early fetal deve10pment.I~ Because a fraction (5% to 15%) of FL cells at day 15.5 also expressed such Fc receptor complexes, we next analyzed whether NK progenitors in FL are confined to this particular subpopulation. To this end, 2.4G2* cells were isolated by cell sorting and tested for their NK progenitor activity by limiting dilution analysis. As shown in Fig 3D, 
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F.L. (with frequencies of NK progenitors of 1/13,000 and 1/34,800, respectively) (Fig 3E) . The average cytotoxicity against YAC-I was also increased, although minimally, in cultures derived from 2.4G2' cells when compared with ex vivo FL cells (Fig 3F) . Note that, in these experiments, the ex vivo unfractionated FL cells were reacted with 2.4G2 in parallel to the 2.4G2+-sorted population to rule out any functional consequences of the 2.4G2 MoAb. Although not shown, we were also able to generate 2.4G2+ NK cells after in vitro culture of day-1 5.5 FL cells depleted of 2.4G2+ cells by cell sorting. Analysis of the frequency of NK progenitors suggests that 2.462-FL contains approximately 1 precursor in 20,000 cells (data not shown). Together, these results suggest that NK progenitors are contained not only within the FcyRII/III+ but also within the FcyRIIIIII-subpopulations of FL cells at day-15.5 gestation.
Ly5. I CD8
To test the capacity of FL cells to differentiate into T cells, FL cells were isolated from day-15.5 C57B1/6 (Ly5.1') fetuses and injected in vivo intrathymically into congenic-irradiated young-adult recipient mice (Ly5.2+). A total of 1.2 X lo5 cells were injected per thymus, and animals were killed after 13 days. Intrathymic development of donor-type thymocytes was analyzed by three-color immunofluorescence. An example of such an analysis is shown in Fig 4. Donor-type cells (Ly5.1+) were gated (Fig 4, left) and analyzed for expression of CD4 and CD8 (Fig 4, right panel) . In this experiment, 87% of donor-type Ly5.1' cells, which were all CD4-CD8-at the time of injection (Table I) , had matured into CD4+CD8+ thymocytes. As expected, we failed to detect Ly5.1' cells in the thymuses of control animals injected with only PBS (Fig 4, top panels) .
T-cell progenitor activity of FL subpopulations.
Day-15.5 FL cells obtained from C57B1/6 (Ly5.1') fetuses were then fractionated, as in Fig 2, according to differences in density, and cells from each of the 5 individual fractions were subsequently injected intrathymically into an irradiated Ly5.2' host. Twelve days after injection, the number of donor-derived Ly5.1' cells per 50,000 thymocytes was evaluated. Although animals injected with unfractionated FL cells were found to have Ly5.l' cells within their thymus, substantially higher numbers were recovered when cells from F1 or F2 fractions were injected ( Table 2 , experiment I). Interestingly, fractions F3, F4, and F5 were found to contain little or no T-cell progenitor activity. Although not shown, a substantial fraction (50% to 90%) of Ly5.1' cells recovered after injection of FL; F1 or F2 cells coexpressed CD4 and CD8 and, therefore, had differentiated in vivo along the T-cell lineage. These results were confirmed in a second independent set of experiments using day-14.5 FL cells. Although only 3 fractions were tested in that analysis, T-cell progenitors were again restricted to cells that had a low density (1.05 < d < 1.07 g/mL) and were not in the cell population with d > I .07 g/mL (Table 2, experiment 2). In addition, when highly purified 2.4G2+ and 2.4G2-FL subpopulations were isolated by cell sorting and injected intrathymically, both FcyRII/III+ and Fcy RIIIIII-FL cells were found to contain precursors of T lymphocytes (data not shown). C57B1/6 (Ly5.1)-derived, fetal day-1 5.5 (experiment 1) or day-14.5 (experiment 2) liver cells were isolated and separated over a Percoll gradient as described in the Materials and Methods. Unfractionated cells as well as cells from individual fractions were injected intrathymically (using 1 O5 cells/thymus) into irradiated (450 rad) B6Ly5.2 congenic animals. Twelve days after intrathymic injection, animals were killed and the number of donor-derived (Ly5.1+) cells per 50,000 thymocytes was evaluated. Each number represents a determination obtained from a single animal. Analysis of CD4 versus CD8 expression on donor-type cells was performed in experiment 1 and showed that 50% to 90% of Ly5. l'cells have matured into double-positive CD4+CD8+ cells in 12 days. Percoll dilutions used in experiment 1 are as described in Fig 3A. Percoll dilutions used in experiment 2 and corresponding densities (in grams per milliliter) are 40% (1.05). 50% (1.06). 58% (1.07). and 82% (1.10). Fractions F1 to F3 (top to bottom of the gradient) correspond to cells harvested a t each interface. After defining the specific culture conditions that allow for the expression of NK cells from murine FL progenitors, we then analyzed the subpopulations of day-15.5 FL cells containing NK progenitors. Fractionation of FL based on differences in buoyant density showed that NK precursors in day-15.5 FL cells are found in the fractions of cells with 1.04 < d < I .08 g/mL. Interestingly, FL subpopulations containing NK progenitors are capable of differentiating in vivo into CD4+CD8+ thymocytes after direct intrathymic transfer into congenic host animals and, therefore, also contain T-cell progenitors. In contrast, precursors for both T and NK lineages were absent from high-density FL cells (d > 1.08 g/mL). Given that the latter represent 240% of day-15.5 FL cells, centrifugation over a discontinuous density gradient provides a rapid method to remove a substantial fraction of FL cells that lacks both T-and NK-cell-progenitor activity. Interestingly, it has recently been shown that multipotent stem cells from FL, defined by expression of the surface marker AA4.1 as well as the absence or low level of surface molecules associated with mature hematopoietic cells (Lin"), are predominantly found in the cell population with a density of 1.065 -= d < 1.070 g/mL.27 This population is predicted to be contained in our F2 (Fig 3A and B; and Table 2 , experiment 1). The NK-or T-cell-progenitor activity present in day-15.5 FL could either be directly derived from such multipotent stem cells or from an intermediate precursor. However, we observed that most AA4. If cells in day-15.5 FL (representing 5 1% of the total population) are B220' (data not shown) and, therefore, are committed to the early stages of B-cell differentiation." In contrast, AA4.1' day-1 2 FL cells are mostly B220-(our unpublished observation and Cumano and Paige2') and presumably represent uncommitted stem cells. It remains to be determined whether NK-and/or T-cell-progenitor activities can be separated from or are restricted to AA4.1+ FL cells.
A bipotential precursor for both B lymphocytes and macrophages was characterized in murine FL and was shown to differ from multipotential-hematopoietic stem cells in its inability to sustain production of erythroid cells in in vivo long-term multilineage reconstitution assays.29 Our results suggest that T and NK precursors in day-15.5 FL cells have similar physical characteristics but do not directly show the existence of such a bipotential precursor for T and NK cells. However, several observations support the notion that T lymphocytes and NK cells may arise from a common progenitor. First, we recently reported that a population of FcyRII/III+ fetal thymocytes could give rise to both T-and NK-cell lineages in a microenvironment-dependent manner.I3 In addition, NK cells derived from human FL were found to express cytoplasmic CD37, 6, t, and P proteins. It has been suggested from this observation that FL cells expressing intracellular components of the CD3 complex could represent a common progenitor for human T and NK C~I I S . '~,~~ Altogether, the physical separation method described herein constitutes a first step to enrich FL cells for both T and NK precursors. To further analyze the relationship between both progenitors, additional fractionation of FL cells could be achieved based on additional physical characteristics (ie, size and granularity) and surface expression of various receptors (eg, HSA, Pgpl, VLA-4, and AA4.1). Ultimately, enrichment for one or both precursor activities into a specific fraction of FL cells should allow the introduction of a genetic (ie, retrovirally introduced) marker that will facilitate the analysis of the fate of clonal cellular populations both in vivo and in vitro. 2733L In light of our recent observation that intrathymic-T and -NK progenitors express FcyRII/III during early fetal development,13 we directly tested whether the NK progenitor activity was restricted to 2.4G2+ cells in day-15.5 FL. We observed only an approximately 2.7-fold enrichment in NK progenitors in the 2.4G2' sorted population (285% 2.4G2+) as opposed to unsorted FL cells (8% 2.4G2') ( Fig 3D) . These data suggest that NK progenitors are heterogeneous and are contained within both FcyRII/III+ and FcyRII/IIIsubpopulations. Interestingly, we made a similar observation concerning T-cell progenitors, suggesting that Fc receptors for IgG might be expressed, in at least a fraction of the progenitors, during early T-cell development (data not shown). It has been proposed recently that FcyRII is also expressed early during B-cell de~elopment.'~ Of note, the expression of FcyRIII (CD16) or FcyRII is preserved in mature NK cells or in B lymphocytes, respectively. In contrast, FcyRII/I11 expression in T cells appears to be maximal during early thymic development and precedes V(D)J rearrangement of the TCR-P chain, but is lost within the thymus during the transition from the double-negative CD4-CD8-stage to the double-positive CD4+CD8+ stage.37
The observation that Fc receptors for IgG are expressed during the early steps of lymphoid development is intriguing in view of the fact that these multimeric receptors are coupled to intracellular components of the signal transduction machinery (ie, protein tyrosine kinase^).^',^^ Because maternal IgG are known to cross the placenta in humans and mice, fetal immune cells could take advantage of the maternal Ig repertoire to develop their effector functions in 
